A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.

in muscle-invasive bladder cancer, MIBC. The publication is now available online and will be in a future print edition of Nature Medicine. The results were also presented at the Society for ...

The patents are for salmonella-based approaches to enhance the efficacy of immune checkpoint inhibitors and elicit immune ...

Patients were further queried to identify those who received adequate BCG induction (defined as ≥ 5 weekly instillations). They then summarized the distribution of this group and the treatments ...

The investigational immunotherapy ZH9 is being developed as an intravesical treatment for the prevention of recurrences in non-muscle invasive bladder cancer. The PARADIGM-1 study (NCT06181266) is ...

Rana R. McKay, MD, discusses the significance of clinical trial data for immunotherapy in muscle-invasive bladder cancer (MIBC) treatment she presented at a Case-Based Roundtable event.

Bladder cancer is one of the most common forms of cancer and is difficult to treat, with a high recurrence rate. Successful Phase II study: Immunotherapy as an alternative to antibiotic treatment for ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free ...

Immunotherapy is used to try to boost the body’s own immune system to attack cancer cells. However, only some patients respond to treatment, explains lead study author Theinmozhi Arulraj, Ph.D., a ...

In addition, corresponding logic gates were constructed to distinguish cancer cells from normal cells and redirect anticancer signal flows to trigger specific cancer immunotherapy ... distinguishing ...